Roivant Sciences Ltd.

NASDAQ:ROIV

11.39 (USD) • At close June 27, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q3
Revenue 7.579.0184.47555.13228.9337.1437.10121.62427.37617.052
Cost of Revenue 0.2050.2592.0523.9784.4123.6683.2664.2149.3868.324
Gross Profit 5.9828.7594.24151.15424.51833.47233.83517.4117.998.728
Gross Profit Ratio 0.790.9710.9480.9280.8470.9010.9120.8050.6570.512
Reseach & Development Expenses 133.261141.595142.349133.208120.902123.717131.984125.133131.857125.533
General & Administrative Expenses 147.092141.545202.881148.5190197.2820156.1900
Selling & Marketing Expenses 1.0940-1.0940000156.1900
SG&A 99.559141.545201.787148.519169.616197.282164.355156.19120.299163.523
Other Expenses 99.63100-110.3870-5,348.41-538.95812.500
Operating Expenses 292.33283.14344.136171.34287.733-5,027.411-242.619293.823252.156289.056
Operating Income -284.965-274.381-341.713-120.186-2665,060.883276.454-276.413-234.166-280.328
Operating Income Ratio -37.644-30.426-76.36-2.18-9.195136.2657.451-12.783-8.554-16.44
Total Other Income Expenses Net 81.91139.868117.3374.5475,364.3374,821.883-50.948-49.6854.95-101.749
Income Before Tax -203.054-234.513-224.38370.145-191.4535,098.337-327.361-326.093-179.216-382.077
Income Before Tax Ratio -26.824-26.005-50.1411.272-6.618137.273-8.824-15.08-6.546-22.407
Income Tax Expense 49.321-25.56812.45812.655-8.95725.6723.7571.752-3.7932.819
Net Income -206.475169.381-230.18495.297-151.1155,096.184-304.327-291.816-33.617-352.014
Net Income Ratio -27.27518.783-51.4381.729-5.223137.216-8.203-13.495-1.228-20.644
EPS -0.290.23-0.310.13-0.1886.37-0.4-0.38-0.045-0.49
EPS Diluted -0.290.23-0.310.12-0.1886.03-0.4-0.38-0.045-0.49
EBITDA -283.54-271.46-222.56588.4275,113.166-310.831-311.342-309.722-163.132-305.421
EBITDA Ratio -37.456-30.102-49.7351.604176.743-8.369-8.392-14.323-5.959-17.911